243 results on '"ORSZAG, ANDREJ"'
Search Results
2. Empagliflozin add-on therapy to closed-loop insulin delivery in type 1 diabetes: a 2 × 2 factorial randomized crossover trial
3. The Prevalence of Autoimmune Diseases in Longstanding Diabetes: Results from the Canadian Study of Longevity in Adults with Type 1 Diabetes
4. Vasopressin associated with renal vascular resistance in adults with longstanding type 1 diabetes with and without diabetic kidney disease
5. Analysis of Prevalence, Magnitude and Timing of the Dawn Phenomenon in Adults and Adolescents With Type 1 Diabetes: Descriptive Analysis of 2 Insulin Pump Trials
6. Sex differences in neuropathy & neuropathic pain: A brief report from the Phase 2 Canadian Study of Longevity in Type 1 Diabetes
7. Elevated plasma cyclic guanosine monophosphate may explain greater efferent arteriolar tone in adults with longstanding type 1 diabetes: A brief report
8. Estimating GFR by Serum Creatinine, Cystatin C, and β2-Microglobulin in Older Adults: Results From the Canadian Study of Longevity in Type 1 Diabetes
9. Sex differences in neuropathic pain in longstanding diabetes: Results from the Canadian Study of Longevity in Type 1 Diabetes
10. Agreement between automated and manual quantification of corneal nerve fiber length: Implications for diabetic neuropathy research
11. Corneal confocal microscopy for identification of diabetic sensorimotor polyneuropathy: a pooled multinational consortium study
12. Validation of cooling detection threshold as a marker of sensorimotor polyneuropathy in type 2 diabetes
13. In Vivo Corneal Confocal Microscopy and Prediction of Future-Incident Neuropathy in Type 1 Diabetes: A Preliminary Longitudinal Analysis
14. Evaluation of a Clinical Tool to Test and Adjust the Programmed Overnight Basal Profiles for Insulin Pump Therapy: A Pilot Study
15. Sensor-Augmented Pump and Multiple Daily Injection Therapy in the United States and Canada: Post-Hoc Analysis of a Randomized Controlled Trial
16. Lower corneal nerve fibre length identifies diabetic neuropathy in older adults with diabetes: results from the Canadian Study of Longevity in Type 1 Diabetes
17. Single- and Dual-Hormone Artificial Pancreas for Overnight Glucose Control in Type 1 Diabetes
18. Insulin Pump Use and Diabetic Ketoacidosis Risk in Type 1 Diabetes: Secular Trends Over 4 Decades.
19. Corneal Confocal Microscopy Predicts the Development of Diabetic Neuropathy: A Longitudinal Diagnostic Multinational Consortium Study
20. Author response for 'Reducing the Need for Carbohydrate Counting in Type 1 Diabetes using Closed-Loop Automated Insulin Delivery (Artificial Pancreas) and Empagliflozin: A Randomised Controlled Non-Inferiority Crossover Pilot Trial'
21. Corneal Confocal Microscopy Predicts the Development of Diabetic Neuropathy : A Longitudinal Diagnostic Multinational Consortium Study
22. Reducing the need for carbohydrate counting in type 1 diabetes using closed‐loop automated insulin delivery (artificial pancreas) and empagliflozin: A randomized, controlled, non‐inferiority, crossover pilot trial
23. Detection of Diabetic Sensorimotor Polyneuropathy by Corneal Confocal Microscopy in Type 1 Diabetes: A concurrent validity study
24. Heart Rate Variability and Sensorimotor Polyneuropathy in Type 1 Diabetes
25. 1119-P: Alleviating Carbohydrate Counting Burden in Type 1 Diabetes (T1D) with the Artificial Pancreas and Empagliflozin (EMPA)
26. Prediction of Incident Diabetic Neuropathy Using the Monofilament Examination: A 4-year prospective study
27. Multi-Site Testing With a Point-of-Care Nerve Conduction Device Can Be Used in an Algorithm to Diagnose Diabetic Sensorimotor Polyneuropathy
28. 126 - Prevalence of Detectable C-peptide in Longstanding Type 1 Diabetes (T1D)
29. 24 - Alleviating Carbohydrate-Counting Burden in Type 1 Diabetes (T1D) Using the Artificial Pancreas (AP) and Sodium Glucose-Linked Transporter 2 Inhibition
30. 15 - Prediction of Future Neuropathy Onset Using Corneal Nerve Fibre Length (CNFL): A Longitudinal Multinational Consortium Study
31. 1737-P: Prevalence of Autoimmune Diseases in Longstanding Diabetes: Results from the Canadian Study of Longevity in Type 1 Diabetes
32. Risk factors for diabetic kidney disease in adults with longstanding type 1 diabetes: results from the Canadian Study of Longevity in Diabetes
33. Corneal confocal microscopy for identification of diabetic sensorimotor polyneuropathy: a pooled multinational consortium study
34. Retinopathy and RAAS Activation: Results From the Canadian Study of Longevity in Type 1 Diabetes
35. The relationships between markers of tubular injury and intrarenal haemodynamic function in adults with and without type 1 diabetes: Results from the Canadian Study of Longevity in Type 1 Diabetes
36. Analysis of Prevalence, Magnitude and Timing of the Dawn Phenomenon in Type 1 Diabetes: Descriptive Analysis of 2 Insulin Pump Trials
37. Atherosclerosis and Microvascular Complications: Results From the Canadian Study of Longevity in Type 1 Diabetes
38. The Relationships Between Retinopathy and Other Vascular Complications in Adults with Longstanding Diabetes: Results From the Canadian Study for Longevity in Type 1 Diabetes
39. The Relationships between Retinopathy and Other Vascular Complications in Adults with Long-Standing Diabetes—Results from the Canadian Study of Longevity in Type 1 Diabetes (T1D)
40. Sex Differences in Neuropathy and Neuropathic Pain in Long-Standing Diabetes—Results from the Canadian Study of Longevity in Type 1 Diabetes
41. Elevated Serum Neutrophil Gelatinase-Associated Lipocalin (NGAL) and Intrarenal Hemodynamic Dysfunction in Type 1 Diabetes (T1D)
42. Analysis of Prevalence, Magnitude, and Timing of the Dawn Phenomenon in Type 1 Diabetes—Descriptive Analysis of Two Insulin Pump Trials
43. Validity of a point-of-care nerve conduction device for polyneuropathy identification in older adults with diabetes: Results from the Canadian Study of Longevity in Type 1 Diabetes
44. Adiposity Impacts Intrarenal Hemodynamic Function in Adults With Long-standing Type 1 Diabetes With and Without Diabetic Nephropathy: Results From the Canadian Study of Longevity in Type 1 Diabetes
45. Renin-angiotensin-aldosterone system activation in long-standing type 1 diabetes
46. Diabetes Care Disparities in Long-standing Type 1 Diabetes in Canada and the U.S.: A Cross-sectional Comparison
47. Estimated Glomerular Filtration Rate by Serum Creatinine Lacks Accuracy and Precision in Older Adults with and without Type 1 Diabetes
48. Renin Angiotensin Aldosterone System (RAAS) Activation and Diabetic Nephropathy (DN) Resistor Status in Longstanding Type 1 Diabetes
49. Point-of-Care Nerve Conduction for the Identification of Neuropathy in Older Adults with Type 1 Diabetes
50. Exploring the optimal diagnostic threshold value of corneal nerve fibre length (CNFL) for diabetic neuropathy (DN) identification
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.